Yoshitaka Arase

Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

Makoto Chuma, Haruki Uojima, Nobuhiro Hattori et al. · Hepatology Research · 2021 · 50 citations

Pharmacy, Oncology, Pharmacotherapy +13

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi et al. · The Oncologist · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +15

Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients

Shunji Hirose, Koshi Matsumoto, Masayuki Tatemichi et al. · PLoS ONE · 2020 · 38 citations · Full text

Medicine, Internal Medicine, Autopsy Pathology +8

Recessive Inheritance of Population-Specific Intronic LINE-1 Insertion Causes a Rotor Syndrome Phenotype

Tatehiro Kagawa, Akira Oka, Yoshinao Kobayashi et al. · Human Mutation · 2014 · 32 citations

Life Sciences, Genetics, Genomics +13

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Yoshitaka Arase, Koichi Shiraishi, Kazuya Anzai et al. · Clinical Drug Investigation · 2019 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17